Publikationen der ABCSG 2024-2023
Finden Sie hier eine Übersicht zu peer-reviewed Fachpublikationen (Vollpublikationen), an denen die ABCSG maßgeblich beteiligt war
Axillary Surgery in Breast Cancer — Primary Results of the INSEMA Trial
T. Reimer, A. Stachs, K. Veselinovic, T. Kuhn, J. Heil, S. Polata, F. Marme, T. Muller, G. Hildebrandt, D. Krug, B. Ataseven, R. Reitsamer, S. Ruth, C. Denkert, I. Bekes, D.-M. Zahm, M. Thill, M. Golatta, J. Holtschmidt, M. Knauer, V. Nekljudova, S. Loibl, and B. Gerber
Published on December 12, 2024, at NEJM.org.
https://www.nejm.org/doi/full/10.1056/NEJMoa2412063
Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trial
Alexios Matikas, Andri Papakonstantinou, Sibylle Loibl , Günther G. Steger, Michael Untch, Hemming Johansson, Nikos Tsiknakis, Mats Hellström, Richard Greil, Volker Möbus, Michael Gnant, Jonas Bergh, Theodoros Foukakis
THE LANCET Regional Health – Europe
Volume 49 101162, February 2025
Published Online 03 December 2024
https://doi.org/10.1016/j.lanepe.2024.101162
Monocyte subsets in breast cancer patients under treatment with aromatase inhibitor and mucin-1 cancer vaccine
Viktoria Knöbl, Lukas Maier, Stefan Grasl, Carmen Kratzer, Felix Winkler, Vanessa Eder, Hubert Hayden, Maria Amparo Sahagun Cortez, Monika Sachet, Rudolf Oehler, Sophie Frantal, Christian Fesl, Karin Zehetner, Georg Pfeiler, Rupert Bartsch, Florian Fitzal, Christian F. Singer, Martin Filipits, Michael Gnant & Christine Brostjan
Journal of Translational Medicine (2024) 22:913
https://doi.org/10.1186/s12967-024-05659-w
Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14–13/PrE0109)
Guilherme Nader-Marta, Christian Singer, Dominik Hlauschek, Angela DeMichele, Paolo Tarantino, Evandro de Azambuja, Georg Pfeiler, Miguel Martin, Justin M. Balko, Zbigniew Nowecki, Marija Balic, Adam M. Brufsky, Arlene Chan, Patrick G. Morris, Tufia Haddad, Sibylle Loibl, Yuan Liu, Lidija Soelkner, Christian Fesl, Erica L. Mayer & Michael Gnant on behalf of the PALLAS groups and investigators
Breast Cancer Research (2024) 26:140
Published: 07 October 2024
https://doi.org/10.1186/s13058-024-01899-2
Standardized Definitions for Efficacy End Points for Adjuvant Trials—The Updated STEEP Criteria
Dominik Hlauschek, MSc; Christian Fesl; PhD, Michael Gnant, MD
JAMA Oncology
Published online September 19, 2024
doi:10.1001/jamaoncol.2024.3888
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial
Alexios Matikas, MD, PhD; Volker Mobus, MD, PhD; Richard Greil, MD, PhD; Anne Andersson, MD, Ph; Gunther G. Steger, MD; Michael Untch, MD, PhD; Tommy Fornander, MD, Ph; Per Malmstrom, MD, PhD; Sabine Schmatloch, MD; Hemming Johansson, BSc; Mats Hellstrom, BSc; Yvonne Brandberg, PhD; Michael Gnant, MD, PhD; Sibylle Loibl, MD, PhD; Theodoros Foukakis, MD, PhD; and Jonas Bergh, MD, PhD; on behalf of the SweBCG, ABCSG and GBG
Journal of Clinical Oncology
July 17th, 2024
https://ascopubs.org/doi/10.1200/JCO.24.00178
Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression
Eva Valentina Klocker, Samantha Hasenleithner, Rupert Bartsch, Simon P. Gampenrieder, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Michael Hubalek, Katja Schmitz, Zsuzsanna Bago-Horvath, Andreas Petzer, Sonja Heibl, Ellen Heitzer, Marija Balic, and Michael Gnant
Molecular Oncology, 12.06.2024, Online ahead of print
https://doi.org/10.1002/1878-0261.13671
Download
Palbociclib combined with endocrine treatment in hormone receptor-positive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy: subgroup analyses of premenopausal patients in PENELOPE-B
Marmé F, Martin M, Untch M, Thode C, Bonnefoi H, Kim SB, Bear H, Mc Carthy N, Gelmon K, García-Sáenz JA, Kelly CM, Reimer T, Valota O, Toi M, Rugo HS, Gnant M, Makris A, Bassy M, Zhang Z, Furlanetto J, Nekljudova V, Loibl S.
ESMO Open. 2024 Jun 4;9(6):103466. Online ahead of print.PMID: 38838498
https://doi.org/10.1016/j.esmoop.2024.103466
Download
Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy
Hatem A. Azim Jr, MD, Ph; Samuel M. Niman, MS; Ann H. Partridge, MD, MPH; Isabelle Demeestere, MD, PhD; Monica Ruggeri; Marco Colleoni, MD; Cristina Saura, MD, Ph; Chikako Shimizu, MD; Anna B. Saetersdal, MD; Judith R. Kroep, MD, PhD; Audrey Mailliez; Ellen Warner, MD; Virginia F. Borges, MD; Frederic Amant, MD; Andrea Gombos, MD; Akemi Kataoka, MD; Christine Rousset-Jablonski, MD, PhD; Simona Borstnar, MD, PhD; Junko Takei, MD; Jeong Eon Lee, MD, PhD; Janice M. Walshe, MD; Manuel Ruiz-Borrego, MD; Halle C.F. Moore, MD; Christobel Saunders, MD; Vesna Bjelic-Radisic, MD, PhD; Snezana Susnjar, MD; Fatima Cardoso, MD; Natalie J. Klar, MD; Tanja Spanic, PhD; Kathryn Ruddy, MD, MPH; Martine Piccart, MD, PhD; Larissa A. Korde, MD, MPH; Aron Goldhirsch, MD†; Richard D. Gelber, PhD; Olivia Pagani, MD; and Fedro A. Peccatori, MD, PhD
J Clin Oncol 00:1-11, Published May 29, 2024
https://doi.org/10.1200/JCO.23.02292
Prediction of survival after neoadjuvant therapy in locally advanced rectal cancer – a retrospective analysis
Piringer G, Ponholzer F, Thaler J, Bachleitner-Hofmann T, Rumpold H, de Vries A, Weiss L, Greil R, Gnant M, Öfner D.
eCollection 2024.PMID: 38817890. Front Oncol. 2024 May. 16;14:1374592.
https://doi.org/10.3389/fonc.2024.1374592
Download
The future of clinical trials – goals, ideas, and discussion
Michael Gnant, Manuela Gili, Magdalena Schwarz, Christian Fesl, Dominik Hlauschek, Anita Jallitsch-Halper, Hannes Fohler
memo – Magazine of European Medical Oncology, 18.04.2024, Volume 17, 1/2024
https://doi.org/10.1007/s12254-024-00969-7
Download
Assessing Knowledge, Competence, and Performance Following Web-Based Education on Early Breast Cancer Management: Health Care Professional Questionnaire Study and Anonymized Patient Records Analysis.
Gnant M, Abdullah KL, Boyle F, Huang CS, Bickford K, Neunie S, Noble A, Nunn A, Sproat C, Harbeck N, Barrios C
JMIR Formative Research
Published online: 21 March 2024
DOI: 10.2196/50931. PMID: 38512328
Explained variation and degrees of necessity and of sufficiency for competing risks survival data.
Gleiss A, Gnant M, Schemper M
Biometrical Journal Published online: 2024 Mar;66(2): e2300140
DOI: 10.1002/bimj.202300140. PMID: 38409618
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Loibl S, André F, Bachelot T, Barrios CH, Bergh J, Burstein HJ, Cardoso MJ, Carey LA, Dawood S, Del Mastro L, Denkert C, Fallenberg EM, Francis PA, Gamal-Eldin H, Gelmon K, Geyer CE, Gnant M, Guarneri V, Gupta S, Kim SB, Krug D, Martin M, Meattini I, Morrow M, Janni W, Paluch-Shimon S, Partridge A, Poortmans P, Pusztai L, Regan MM, Sparano J, Spanic T, Swain S, Tjulandin S, Toi M, Trapani D, Tutt A, Xu B, Curigliano G, Harbeck N; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org.
Annals of Oncology Published online: 2024 Feb; 35(2):159-182
DOI: 10.1016/j.annonc.2023.11.016. Epub 2023 Dec 13. PMID: 38101773
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, Georg Pfeiler, Christian F. Singer, Stefan Halper, Günther Steger, Christoph Suppan, Simon P. Gampenrieder, Ruth Helfgott, Daniel Egle, Martin Filipits, Raimund Jakesz, Lidija Sölkner, Christian Fesl, Michael Gnant, Florian Fitzal & Richard Greil
Breast Cancer Research and Treatment
Published online: 25 January 2024
DOI: https://doi.org/10.1007/s10549-023-07186-6
Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients
Kerstin Wimmer, Monika Sachet, Cristiano Ramos, Sophie Frantal, Hanna Birnleitner, Christine Brostjan, Ruth Exner, Martin Filipits, Zsuzsanna Bago-Horvath, Margaretha Rudas, Rupert Bartsch, Michael Gnant, Christian F. Singer, Marija Balic, Daniel Egle, Rudolf Oehler & Florian Fitzal
Journal of Experimental & Clinical Cancer Research volume 42, Article number: 300 (2023)
Published: 14 November 2023
DOI: https://doi.org/10.1186/s13046-023-02876-x
ASO Visual Abstract: Impact of Imaging-Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node-Positive Breast Cancer: Prospective Cohort Study Within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Walter P. Weber MD, Martin Heidinger MD, Stefanie Hayoz PhD, Zoltan Matrai MD, PhD, Christoph Tausch MD, Guido Henke MD, Daniel R. Zwahlen MD, Günther Gruber MD, Frank Zimmermann MD, Giacomo Montagna MD, MPH, Mariacarla Andreozzi PhD, Maite Goldschmidt MSc, Alexandra Schulz MSc, Andreas Mueller MD, Markus Ackerknecht PhD, Ekaterini Christina Tampaki MD, PhD, Vesna Bjelic-Radisic MD, Christian Kurzeder MD, Ákos Sávolt MD, PhD, Viktor Smanykó MD, Daniela Hagen MD, Dieter J. Müller MD, Michael Gnant MD, Sibylle Loibl MD, Florian Fitzal MD, Pagona Markellou MD, Inga Bekes MD, Daniel Egle MD, Jörg Heil MD & Michael Knauer MD, PhD
Annals of Surgical Oncology (2023)
Published: 13 November 2023
DOI: https://doi.org/10.1245/s10434-023-14489-x
Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer
Maximilian Marhold, Simon Udovica, Anna Halstead, Mona Hirdler, Muna Ferner, Kerstin Wimmer, Zsuzsanna Bago-Horvath, Ruth Exner, Florian Fitzal, Kathrin Strasser-Weippl, Tim Robinson & Rupert Bartsch
ONCOIMMUNOLOGY
Published online: 13 November 2023
DOI: https://doi.org/10.1080/2162402X.2023.2275846
Patient-reported outcomes in high-risk HR+/HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study
José Angel García-Sáenz, Frederik Marmé, Michael Untch, Hervé Bonnefoi, Sung-Bae Kim, Harry Bear, Nicole Mc Carthy, Karen Gelmon, Miguel Martin, Catherine M. Kelly, Toralf Reimer, Masakazu Toi, Ernest Law, Helen Bhattacharyya, Michael Gnant, Andreas Makris, Sabine Seiler, Nicole Burchardi, Valentina Nekljudova, Sibylle Loibl, Hope S. Rugo
European Journal of Cancer
Published: November 5th, 2023
DOI: https://doi.org/10.1016/j.ejca.2023.113420
Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023.
Curigliano G, Burstein HJ, Gnant M, Loibl S, Cameron D, Regan MM, Denkert C, Poortmans P, Weber WP, Thürlimann B;
St Gallen Consensus Conference Panelists 2023.
Ann Oncol. 2023 Nov;34(11):970-986.
DOI: 10.1016/j.annonc.2023.08.017. Epub 2023 Sep 6.PMID: 37683978
https://pubmed.ncbi.nlm.nih.gov/37683978/
Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
Lancet 2023; 401: 1277–92
DOI: https://doi.org/10.1016/S0140-6736(23)01082-6
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01082-6/fulltext
Open Access, Published: November 03, 2023
Impact of Imaging‑Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node‑Positive Breast Cancer: Prospective Cohort Study Within TAXIS (OPBC‑03, SAKK 23/16, IBCSG 57‑18, ABCSG‑53, GBG 101
Walter P. Weber, MD, Martin Heidinger, MD, Stefanie Hayoz, PhD , Zoltan Matrai, MD, PhD , Christoph Tausch, MD, Guido Henke, MD, Daniel R. Zwahlen, MD , Günther Gruber, MD , Frank Zimmermann, MD, Giacomo Montagna, MD, MPH, Mariacarla Andreozzi, PhD, Maite Goldschmid, Alexandra Schulz, Andreas Mueller, MD, Markus Ackerknecht, PhD, Ekaterini Christina Tampaki, MD, PhD, Vesna Bjelic‑Radisic, MD, Christian Kurzeder, MD, Ákos Sávolt, MD, PhD, Viktor Smanykó, MD, Daniela Hagen, MD, Dieter J. Müller, MD, Michael Gnant, MD, Sibylle Loibl, MD, Florian Fitzal, MD, Pagona Markellou, MD , Inga Bekes, MD , Daniel Egle, MD, Jörg Heil, MD, and Michael Knauer, MD, PhD
Annals of Surgical Oncology
DOI: 10.1245/s10434-023-14404-4
https://link.springer.com/article/10.1245/s10434-023-14404-4
Published 30 October 2023
Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Huober J, Weder P, Ribi K, Thürlimann B, Thery JC, Li Q, Vanlemmens L, Guiu S, Brain E, Grenier J, Dalenc F, Levy C, Savoye AM, Müller A, Membrez-Antonioli V, Gérard MA, Lemonnier J, Hawle H, Dietrich D, Boven E, Bonnefoi H;
Swiss Group for Clinical Cancer Research, Unicancer Breast Group, and Dutch Breast Cancer Research Group.
JAMA Oncol. 2023 Oct 1;9(10):1381-1389.
DOI: 10.1001/jamaoncol.2023.2909.PMID: 37561451
https://pubmed.ncbi.nlm.nih.gov/37561451/
Explaining risks and benefits of loco-regional treatments to patients.
Beltran-Bless AA, Kacerovsky-Strobl S, Gnant M.Breast.
2023 Oct;71:132-137. Epub 2023 Aug 22.PMID: 37634470
DOI: 10.1016/j.breast.2023.08.006.
https://pubmed.ncbi.nlm.nih.gov/37634470/
LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study
Gudrun Piringer, Thomas Grienberger, Josef Thaler et al.
https://doi.org/10.3389/fonc.2023.1231600,
Frontiers in Oncology, 09.08.2023
Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer
Walter P. Weber, MD; Zoltan Matrai, MD, PhD; Stefanie Hayoz, PhD; et al
von ABCSG-Seite als Co-Autoren vertreten sind F. Fitzal, M. Gnant, D. Egle
JAMA Surg. Published online July 19, 2023. doi:10.1001/jamasurg.2023.2840
https://jamanetwork.com/journals/jamasurgery/fullarticle/2807463
Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors: existing and emerging differences.
Johnston S, Emde A, Barrios C, Srock S, Neven P, Martin M, Cameron D, Janni W, Gnant M.
JNCI Cancer Spectr. 2023 Jul 3;7(4):pkad045.
DOI: 10.1093/jncics/pkad045.PMID: 37369022
https://pubmed.ncbi.nlm.nih.gov/37369022/
Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Elfgen C, Leo C, Kubik-Huch RA, Muenst S, Schmidt N, Quinn C, McNally S, van Diest PJ, Mann RM, Bago-Horvath Z, Bernathova M, Regitnig P, Fuchsjäger M, Schwegler-Guggemos D, Maranta M, Zehbe S, Tausch C, Güth U, Fallenberg EM, Schrading S, Kothari A, Sonnenschein M, Kampmann G, Kulka J, Tille JC, Körner M, Decker T, Lax SF, Daniaux M, Bjelic-Radisic V, Kacerovsky-Strobl S, Condorelli R, Gnant M, Varga Z.Virchows
Arch. 2023 Jul;483(1):5-20.
DOI: 10.1007/s00428-023-03566-x. Epub 2023 Jun 17.PMID: 37330436
https://pubmed.ncbi.nlm.nih.gov/37330436/
Managing a Long and Winding Road: Estrogen Receptor-Positive Breast Cancer.
Gnant M, Turner NC, Hernando C.
Am Soc Clin Oncol Educ Book. 2023 Jun;43:e390922.
DOI: 10.1200/EDBK_390922.PMID: 37319380
https://pubmed.ncbi.nlm.nih.gov/37319380/
Uncertainties and controversies in axillary management of patients with breast cancer.
Weber WP, Davide Gentilini O, Morrow M, Montagna G, de Boniface J, Fitzal F, Wyld L, Rubio IT, Matrai Z, King TA, Saccilotto R, Galimberti V, Maggi N, Andreozzi M, Sacchini V, Castrezana López L, Loesch J, Schwab FD, Eller R, Heidinger M, Haug M, Kurzeder C, Di Micco R, Banys-Paluchowski M, Ditsch N, Harder Y, Paulinelli RR, Urban C, Benson J, Bjelic-Radisic V, Potter S, Knauer M, Thill M, Vrancken Peeters MJ, Kuemmel S, Heil J, Gulluoglu BM, Tausch C, Ganz-Blaettler U, Shaw J, Dubsky P, Poortmans P, Kaidar-Person O, Kühn T, Gnant M.
Cancer Treat Rev. 2023 Jun;117:102556.
DOI: 10.1016/j.ctrv.2023.102556. Epub 2023 Apr 23.PMID: 37126938
https://pubmed.ncbi.nlm.nih.gov/37126938/
Trends in use of neoadjuvant systemic therapy in patients with clinically node‑positive breast cancer in Europe: prospective TAXIS study (OPBC‑03, SAKK 23/16, IBCSG 57‑18, ABCSG‑53, GBG 101)
Tausch et al
von ABCSG-Seite als Co-Autoren vertreten sind F. Fitzal, M. Gnant, D. Egle, C. Hager. K. Reisenberger, C. Singer
>Breast Cancer Res Treat. 2023; 201(2): 215–225.
Published online 2023 Jun 25. doi: 10.1007/s10549-023-06999-9
Updated Austrian treatment algorithm for metastatic triple-negative breast cancer.
Bartsch R, Rinnerthaler G, Petru E, Egle D, Gnant M, Balic M, Sliwa T, Singer C.
Wien Klin Wochenschr. 2024 Jun;136(11-12):347-361.
DOI: 10.1007/s00508-023-02254-9. Epub 2023 Sep 8.PMID: 37682349
https://pubmed.ncbi.nlm.nih.gov/37682349/
Impact of BMI in Patients With Early Hormone Receptor–Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial
Georg Pfeiler, Dominik Hlauschek, Erica L. Mayer et al
DOI: 10.1200/JCO.23.00126 Journal of Clinical Oncology
https://ascopubs.org/doi/abs/10.1200/JCO.23.00126
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
C Fesl, M Gnant, L Sölkner, G G Steger (Groups (lead investigators) contributing data)
Lancet 2023 Apr 15;401(10384):1277-1292.doi: 10.1016/S0140-6736(23)00285-4
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00285-4/fulltext
St. Gallen/Vienna 2023: Optimization of Treatment for Patients with Primary Breast Cancer – A Brief Summary of the Consensus Discussion.
Balic M, Thomssen C, Gnant M, Harbeck
N.Breast Care (Basel). 2023 Apr;18(3):213-222.
DOI: 10.1159/000530584. Epub 2023 Apr 7.PMID: 37383954
https://pubmed.ncbi.nlm.nih.gov/37383954/
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer
Ann H. Partridge, M.D., M.P.H., Samuel M. Niman, M.S., Monica Ruggeri, Fedro A. Peccatori, M.D., Ph.D., Hatem A. Azim, Jr., M.D., Ph.D., Marco Colleoni, M.D., Cristina Saura, M.D., Ph.D., Chikako Shimizu, M.D., Anna B. Sætersdal, M.D., Judith R. Kroep, M.D., Ph.D., Audrey Mailliez, M.D., Ellen Warner, M.D., et al., for the International Breast Cancer Study Group, and the POSITIVE Trial Collaborators†
The New England Journal of Medicine
N Engl J Med 2023; 388:1645-1656
DOI: 10.1056/NEJMoa2212856
IBCSG 48-14
https://www.nejm.org/doi/full/10.1056/NEJMoa2212856?query=featured_home
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12
Ana-Alicia Beltran-Bless Mark J. Clemons Christian Fesl Richard Greil Gregory R. Pond Marija Balic Lisa Vandermeer Vesna Bjelic-Radisic Christian F. Singer Guenther G. Steger Ruth Helfgott Daniel Egle Lidija Sölkner Simon P. Gampenrieder Stephanie Kacerovsky-Strobl Christoph Suppan Magdalena Ritter Gabriel Rinnerthaler Georg Pfeiler Hannes Fohler Dominik Hlauschek John Hilton Michael Gnant
European Journal of Cancer 180 (2023), 108-116, DOI:
(https://doi.org/10.1016/j.ejca.2022.12.003)
Commentary on “Prognosis according to the timing of recurrence in breast cancer”.
Hlauschek D, Gnant M
Ann Surg Treat Res 2023;104:1-9 Annals of Surgical Treatment and Research
Published online: 2 January 2023
DOI: https://doi.org/10.4174/astr.2023.104.1.1
Teilen auf